Nonetheless, according to Dongiovanni and colleagues, LOXL2 (cg04028450) is associated with T2DM, and its upregulation has been observed in nonalcoholic fatty liver disease patients with T2DM [78]. This evidence concerns the gene LOXL2 and metabolic dysfunction-associated steatotic liver disease.